199 related articles for article (PubMed ID: 9028513)
21. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases.
Hübel K; Dale DC; Engert A; Liles WC
J Infect Dis; 2001 Jan; 183(2):321-328. PubMed ID: 11112098
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.
Sachs UJ; Reiter A; Walter T; Bein G; Woessmann W
Transfusion; 2006 Nov; 46(11):1909-14. PubMed ID: 17076845
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation.
Bhatia S; McCullough J; Perry EH; Clay M; Ramsay NK; Neglia JP
Transfusion; 1994 Mar; 34(3):226-32. PubMed ID: 8146895
[TBL] [Abstract][Full Text] [Related]
24. Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions.
Ofran Y; Avivi I; Oliven A; Oren I; Zuckerman T; Bonstein L; Rowe JM; Dann EJ
Vox Sang; 2007 Nov; 93(4):363-9. PubMed ID: 18070282
[TBL] [Abstract][Full Text] [Related]
25. Granulocyte transfusion in the G-CSF era.
Price TH
Int J Hematol; 2002 Aug; 76 Suppl 2():77-80. PubMed ID: 12430904
[TBL] [Abstract][Full Text] [Related]
26. Multiple granulocyte transfusions facilitating successful unrelated bone marrow transplantation in a patient with very severe aplastic anemia complicated by suspected fungal infection.
Clarke K; Szer J; Shelton M; Coghlan D; Grigg A
Bone Marrow Transplant; 1995 Nov; 16(5):723-6. PubMed ID: 8547874
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors.
Rutella S; Pierelli L; Sica S; Serafini R; Chiusolo P; Paladini U; Leone F; Zini G; D'Onofrio G; Leone G; Piccirillo N
Cytotherapy; 2003; 5(1):19-30. PubMed ID: 12745586
[TBL] [Abstract][Full Text] [Related]
28. Clinical perspectives of granulocyte transfusions: efficacy to date.
Strauss RG
J Clin Apher; 1995; 10(3):114-8. PubMed ID: 8582891
[TBL] [Abstract][Full Text] [Related]
29. Effects of granulocyte-colony-stimulating factor on potential normal granulocyte donors.
McCullough J; Clay M; Herr G; Smith J; Stroncek D
Transfusion; 1999 Oct; 39(10):1136-40. PubMed ID: 10532609
[TBL] [Abstract][Full Text] [Related]
30. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors.
Stroncek DF; Clay ME; Smith J; Ilstrup S; Oldham F; McCullough J
Transfusion; 1996 Jul; 36(7):596-600. PubMed ID: 8701454
[TBL] [Abstract][Full Text] [Related]
31. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation.
Price TH; Bowden RA; Boeckh M; Bux J; Nelson K; Liles WC; Dale DC
Blood; 2000 Jun; 95(11):3302-9. PubMed ID: 10828009
[TBL] [Abstract][Full Text] [Related]
32. Granulocyte transfusion: stimulation of low dose granulocyte colony-stimulating factor in donors for leukapheresis.
Nomura A; Ohga S; Matsuzaki A; Kai T; Inaba S; Suda M; Ueda K
Acta Paediatr Jpn; 1996 Aug; 38(4):317-21. PubMed ID: 8840537
[TBL] [Abstract][Full Text] [Related]
33. Storage of G-CSF-mobilized granulocyte concentrates.
Lightfoot T; Leitman SF; Stroncek DF
Transfusion; 2000 Sep; 40(9):1104-10. PubMed ID: 10988314
[TBL] [Abstract][Full Text] [Related]
34. Granulocytes harvested following G-CSF-enhanced leukocyte recovery retain their functional capacity during in vitro culture for 72 hours.
Murea S; Fruehauf S; Zeller WJ; Haas R
J Hematother; 1996 Aug; 5(4):351-7. PubMed ID: 8877710
[TBL] [Abstract][Full Text] [Related]
35. Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction.
Massey E; Paulus U; Doree C; Stanworth S
Cochrane Database Syst Rev; 2009 Jan; (1):CD005341. PubMed ID: 19160254
[TBL] [Abstract][Full Text] [Related]
36. Use of G-CSF for granulocyte transfusion therapy.
Hübel K; Dale DC; Engert A; Liles WC
Cytokines Cell Mol Ther; 2000 Jun; 6(2):89-95. PubMed ID: 11108574
[TBL] [Abstract][Full Text] [Related]
37. Administration of G--CSF plus dexamethasone produces greater granulocyte concentrate yields while causing no more donor toxicity than G--CSF alone.
Stroncek DF; Yau YY; Oblitas J; Leitman SF
Transfusion; 2001 Aug; 41(8):1037-44. PubMed ID: 11493736
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte collection efficiency and yield are enhanced by the use of a higher interface offset during apheresis of donors given granulocyte-colony-stimulating factor.
Adkins D; Ali S; Despotis G; Dynis M; Goodnough LT
Transfusion; 1998 Jun; 38(6):557-64. PubMed ID: 9661689
[TBL] [Abstract][Full Text] [Related]
39. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia.
Lowenthal RM; Grossman L; Goldman JM; Storring RA; Buskard NA; Park DS; Murphy BC; Spiers AS; Galton DA
Lancet; 1975 Feb; 1(7903):353-8. PubMed ID: 46510
[TBL] [Abstract][Full Text] [Related]
40. Combined chemotherapy and granulocyte colony-stimulating factor (G-CSF) mobilise large numbers of peripheral blood progenitor cells in pretreated patients.
Lickliter JD; Begley CG; Boyd AW; Szer J; Grigg AP
Leuk Lymphoma; 1994 Sep; 15(1-2):91-7. PubMed ID: 7532059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
